The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Verona Pharma Plc ADR’s stock clocked out at $74.09, down -0.86% from its previous closing price of $74.73. In other words, the price has decreased by -$0.86 from its previous closing price. On the day, 0.76 million shares were traded.
Ratios:
To gain a deeper understanding of VRNA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.73 and its Current Ratio is at 8.86. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 1.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on April 28, 2025, initiated with a Buy rating and assigned the stock a target price of $100.
On April 21, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $80.
On January 10, 2025, ROTH MKM started tracking the stock assigning a Buy rating and target price of $68.ROTH MKM initiated its Buy rating on January 10, 2025, with a $68 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when VIKAS SINHA bought 20,000 shares for $72.58 per share.
Fisher Andrew sold 80,000 shares of VRNA for $685,600 on May 15 ’25. The General Counsel now owns 359,999 shares after completing the transaction at $8.57 per share. On May 14 ’25, another insider, ACKERMANN CHRISTINA, who serves as the Director of the company, sold 40,000 shares for $8.44 each. As a result, the insider received 337,600 and left with 41,880 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 53.20 while its Price-to-Book (P/B) ratio in mrq is 27.84.
Stock Price History:
Over the past 52 weeks, VRNA has reached a high of $75.47, while it has fallen to a 52-week low of $11.39. The 50-Day Moving Average of the stock is 14.54%, while the 200-Day Moving Average is calculated to be 57.67%.
Shares Statistics:
A total of 85.13M shares are outstanding, with a floating share count of 76.70M. Insiders hold about 9.90% of the company’s shares, while institutions hold 84.96% stake in the company.
